Nevertheless, the influence of anti-CXCR3 antibodies on the course of FSGS and IgA nephropathy cannot be excluded and should be checked using bigger groups of patients who are divided into subgroups according to the dosage of ACE inhibitor received. The gene discussed is ACE; the disease is focal segmental glomerulosclerosis.